The real-world safety assessment of Siponimod: A systematic analysis based on the FAERS database

被引：1
|
作者：
Jiang, Ying [1 ]
Lu, Rongrong [1 ]
Du, Zhiqiang [1 ]
Shen, Yuan [1 ]
Zhou, Qin [1 ]
Luan, Peipei [1 ]
Zhu, Haohao [1 ]
机构：
[1] Jiangnan Univ, Wuxi Cent Rehabil Hosp, Affiliated Mental Hlth Ctr, Wuxi 214151, Jiangsu, Peoples R China
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2025年 / 468卷
基金：
中国国家自然科学基金;
关键词：
Adverse event; Siponimod; FAERS;
D O I：
10.1016/j.jns.2024.123364
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Signal mining and analysis of ripretinib adverse events: a real-world pharmacovigilance analysis based on the FAERS database
    Hu, Ye
    Zhang, Linlin
    Gong, Qineng
    Huang, Lei
    Yin, Cunlin
    Miao, Yang
    Wu, Hui
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [42] Data mining and safety analysis of dual orexin receptor antagonists (DORAs): a real-world pharmacovigilance study based on the FAERS database
    Jiang, Manxue
    Li, Hao
    Kong, Lingti
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database
    Osei, Samuel Prince
    Akomaning, Edwin
    Florut, Teodora Francesca
    Sodhi, Mohit
    Lacy, Brian E.
    Aldhaleei, Wafa A.
    Bhagavathula, Akshaya Srikanth
    DIAGNOSTICS, 2024, 14 (24)
  • [44] Assessment the real-world safety of intravitreal dexamethasone implant (Ozurdex): novel insights from a comprehensive pharmacovigilance analysis utilizing the FAERS database
    Zhao, Chao-fu
    Lan, Lina
    Shi, Xing-yu
    Li, Jun
    Fan, Shipei
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [45] Adverse events reporting of edaravone: a real-world analysis from FAERS database
    Shang, Qi
    Zhou, Jie
    Ye, Junchang
    Chen, Maohua
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [46] The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Caruso, I.
    Di Gioia, L.
    Di Molfetta, S.
    Caporusso, M.
    Cignarelli, A.
    Sorice, G. P.
    Laviola, L.
    Giorgino, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (11) : 2671 - 2678
  • [47] The real-world safety profile of pemetrexed and platinum with or without pembrolizumab: insights from a comparative analysis of FAERS database
    Shun Li
    Zhifei Huang
    Xiaoyu Zhong
    Yan Zhou
    Hao Jiang
    BMC Cancer, 25 (1)
  • [48] Differences in safety profiles of anti-herpesvirus medications: a real-world pharmacovigilance study based on the FAERS database
    He, Dan
    Kong, Dexuan
    Zeng, Yanbin
    Han, Meifen
    Zhang, Shunguo
    Li, Zhiling
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [49] The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Events Reporting System (FAERS) database
    Caruso, I.
    Di Gioia, L.
    Di Molfetta, S.
    Caporusso, M.
    Cignarelli, A.
    Sorice, G.
    Laviola, L.
    Giorgino, F.
    DIABETOLOGIA, 2024, 67 : S360 - S360
  • [50] Hemorrhage profile associated with immune checkpoint inhibitors: a systematic review and a real-world study based on the FAERS database
    Chen, Mengting
    He, Zhichao
    Zhu, Jianhong
    Yang, Shan
    Gao, Siyuan
    Wu, Jie
    Ren, Huaying
    Liang, Dan
    Jiang, Wei
    Zou, Ying
    Yu, Xiaoxia
    Wu, Junyan
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (04) : 497 - 511
12345